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To the Editor: After the 
emergence of pandemic (H1N1) 2009 
virus, measures for its control were 
taken quickly (e.g., isolation of affected 
patients and use of gowns, gloves, 
and N95 respirators) when a clinical 
suspicion of pandemic inﬂ  uenza was 
established (1). One population group 
frequently exposed to this virus is 
health care staff. These circumstances 
prompted us to implement a screening 
program for the pandemic (H1N1) 
2009 virus among personnel working 
at our hospital in Marbella, Spain.
Costa del Sol Hospital is a 250-
bed, second-level center located on 
the Mediterranean coast. A proposal 
was made to staff working in the 
emergency and internal medicine 
areas that nasal and pharyngeal 
samples to identify the virus by real-
time PCR should be taken weekly 
over 12 consecutive weeks, from the 
third week of September 2009 to the 
third week of December. In addition 
to providing samples, each worker 
would be asked to complete a health-
status questionnaire regarding his 
or her vaccination record and the 
presence of signs or symptoms. Signs 
and symptoms to be reported in the 
questionnaires included fever, runny 
nose, painful swallowing, coughing, 
sore throat, diarrhea, vomiting, 
headaches, muscle pains, and general 
indisposition; 1 question also asked 
whether, during the previous week, a 
conﬁ  rmed diagnosis of inﬂ  uenza with 
a positive PCR for pandemic (H1N1) 
2009 virus had been made in the 
respondent’s household.
At the outset, 60 members of 
the hospital staff volunteered to 
participate. Those who missed >4 
sample tests, or >2 consecutive ones, 
were considered to have abandoned 
the study. Of the 36 staff members who 
completed the study, 27 were women 
(75%). The participants’ average age 
was 37 years (CI 95%: 34.8–39.4). 
Sixteen were doctors, 16 were nurses, 
2 were nursing auxiliary staff, and 2 
were hospital orderlies. During the 
monitoring period, 5 (13%) subjects 
exhibited coughing, 7 (20%) had runny 
noses, 3 (8%) experienced painful 
swallowing, 6 (16%) had headaches, 
and 1 (2%) felt generally unwell. 
Nearly 75% stated they washed their 
hands with antiseptic lotion >20×/d. 
Three workers were vaccinated 
against seasonal and pandemic 
inﬂ  uenza, while only 1 was vaccinated 
against pandemic (H1N1) 2009 alone. 
None took oseltamivir. Five positive 
samples were identiﬁ  ed (13.8% of the 
study population) being obtained from 
four doctors and one nurse, all women. 
The 4 doctors had signs and symptoms 
for 24–48 hours consisting of fever, 
general indisposition, and coughing; 
none of the 4 required hospitalization. 
The nurse was a woman 26 years of 
age with no inﬂ  uenza symptoms and 
with a positive PCR result on week 5. 
None of these 5 workers had received 
any inﬂ  uenza vaccination.
Three workers reported that a 
diagnosis of pandemic (H1N1) 2009 
inﬂ  uenza had been made with respect 
to a member of their household, but 
none of the workers had a positive 
PCR result. The distribution of positive 
PCR results in our hospital during the 
study is shown in the Figure.
It had previously been hypo-
thesized that the incidence of 
asymptomatic cases would be higher 
than the incidence of symptomatic 
cases (2) overall in persons with 
high exposure (3). However, among 
the study population, only 1 person 
with positive PCR results was 
asymptomatic.
Health care workers may have 
been exposed in a gradual manner 
from the beginning of the outbreak 
to a few symptomatic forms, which 
would explain why so few of them 
were actually affected. Of the workers 
in the emergency department who 
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Figure. Number of PCR-conﬁ  rmed cases of pandemic (H1N1) 2009 virus infection in the 
emergency department (PCR-ER), hospitalized patients (PCR-HP), and participants (PCR-
HS) in a study of screening for pandemic (H1N1) 2009 virus among health care workers, 
Spain, September–December 2009.LETTERS
were not part of the study, none were 
diagnosed with pandemic (H1N1) 
2009 during the study period. 
Our study began during the week 
in September 2009 in which the 
overall rate of incidence of pandemic 
(H1N1) 2009 in Spain reached 77.8 
cases per 100,000 inhabitants (4), a 
level that was above the threshold 
established for the previous inﬂ  uenza 
season, and ended during the week 
in which inﬂ  uenza activity fell below 
this threshold level (5). Therefore, the 
study spanned the full cycle of the 
epidemic. The national peak, with an 
overall rate of incidence of 372.7 cases 
per 100,000 inhabitants, occurred in 
week 10 of our study.
This series included 1 
asymptomatic carrier. We do not know 
if that ﬁ   nding could reﬂ  ect  a  false-
positive test or a low-virulence viral 
presence. 
Notably, among the population 
of health care workers taking part 
in the study, only 4 (11%) had been 
vaccinated against the novel form 
of the inﬂ  uenza A virus, and none of 
them had positive PCR results for 
pandemic (H1N1) 2009 virus. On the 
other hand, 5 (15%) of workers not 
vaccinated had a positive PCR result. 
This ﬁ  nding suggests that, despite the 
climate of uncertainty concerning the 
evolution of the inﬂ  uenza  outbreak, 
hospital workers had a greater fear 
of possible side effects of the vaccine 
than of the disease itself.
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Pandemic (H1N1) 
2009 and HIV 
Infection
To the Editor: In the United 
States during spring and fall of 2009, 
pandemic (H1N1) 2009 inﬂ  uenza A 
virus resulted in 2 major outbreaks 
of disease. Initial reports identiﬁ  ed 
immunosuppression, including HIV 
infection, as a risk factor for the 
development of severe inﬂ  uenza (1–
5). Subsequent reports did not conﬁ  rm 
this association, but the number of 
HIV-infected patients in these studies 
was small (6,7). We describe the 
clinical course of pandemic (H1N1) 
2009 in HIV-infected persons in a US 
hospital.
During 2009, 23 cases of 
laboratory-conﬁ  rmed  pandemic 
(H1N1) 2009 in HIV-infected persons 
were identiﬁ  ed at Harborview Medical 
Center (Seattle, WA, USA) by 
querying the University of Washington 
HIV Information System (a database 
that enables complete capture of all 
HIV testing results at Harborview 
Medical Center) and by querying 
the Harborview Infection Control 
Registry for inﬂ  uenza subtype H1N1 
infections. Most cases occurred during 
October and November. Baseline 
patient characteristics are noted in the 
Table. Most patients who sought care 
had fever and cough; median duration 
of symptoms before seeking care was 
4 days. Overall mortality rate for the 
entire cohort was 8.7%.
Of the 23 patients, only 2 were 
not treated for inﬂ   uenza; each had 
mild signs and symptoms and neither 
required hospital admission. Each of 
the remaining 13 outpatients received 
a 5-day course of treatment with 
oseltamivir. The 8 patients who required 
hospitalization received therapy for a 
median of 6 (range 1–22) days. 
Overall mortality rate among 
HIV-infected patients hospitalized 
for pandemic (H1N1) 2009 infection 
was 25% (2 of 8 patients). The 2 
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